AI-Media Technologies (ASX:AIM) is not the only ASX stock with investors panicking that AI will make it go the way of Blockbuster and Kodak...but there are arguably more signs that the fears are legitimate than most other companies.
We acknowledge anyone from the company or an investor may take issue with that statement. But the share…
Online employment marketplace Seek ( ASX:SEK ) may be formally categorised as ‘Media and Entertainment’ by the ASX, although it is difficult to argue that this company is not a tech company.
Two years ago, it seemed to be in the right place at the right time given the state…
Warnings about the impacts of AI disruption have been made, but there was one warning that appeared to have a greater impact on equity markets than most others (at least recently). A blog post published by Wall Street firm Citrini Research, little known prior to the post, was attributed to an 800-point drop in the…
How has a late 2021 IPO focused on commercial fit outs - as Shape Australia Corporation (ASX:SHA) was and is; managed to find itself <3x higher than its IPO price? It went through one of the toughest times to be in the construction space in living memory, even companies such as Reliance Worldwide (ASX:RWC) with…
Magnificent Seven Tech Stocks and AI are a fascinating pair. It could give them another 1-2 decades of dominance at the top of the tech world, or it could be their undoing. In other words, they could suffer the fates of the first movers they overtook like Blockbuster, MySpace and even Ask Jeeves.
What are the…
Let's take a look at AI IPOs set to happen in 2026. Unfortunately, it is unlikely Australia will see too many for a wide variety of reasons including certain market regulations that are unfavourable relative to other markets as well as Australia's productivity slump. Even Australian AI companies may bypass Bridge St for Wall St,…
Investing in ASX biotechs is a risky business, even more than most other companies on the market. Unless you own one of the large cap biotechs, you are betting that major milestones (such as clinical trial completions and decisions on regulatory approval) will occur right on cue and that they will be favourable to the…
At Stocks Down Under, we've written a lot about crypto, but we have never written a broad Guide to Cryptocurrency and thought it was time to change that.
In this guide we cover many matters investors looking at cryptocurrencies wonder including how to invest, what drives crypto markets, what is out there besides bitcoin and where…
Anthropic did not even exist 5 years ago, but its most recent funding round valued it at US$380bn. The company behind Claude, a major rival to ChatGPT, is more valuable than any company on the ASX (even CBA and BHP) and could IPO later this year. But while many investors would be familiar with OpenAI,…
This article recaps some of the best results this ASX reporting season so far, as well as some of the worst - 6 of each to be exact.
We are looking not so much at the highest profits or losses but perhaps the most extreme reactions and whether or not the results were an unexpected outperformance…
